From 2003 to 2012, we recruited 280 participants with T2DM for the Seoul Metabolic Syndrome cohort who had body weight, visceral fat thickness (VFT), and carotid intima-media thickness (CIMT) measured at intervals of 2 years. According to VFT change, sex-specific quartiles of clinical characteristics and changes of CIMT were determined. Logistic regression models predicted the odds of the progression of CIMTs in each quartile.
During 2 years of observation, VFTs fell by 5.2 ± 13.5 mm in men (P < 0.001) and 3.4 ± 10.5 mm in women (P < 0.001). Progression of CIMT was only significant for women's maximal CIMT (0.031 ± 0.145 mm, P = 0.012), while significant improvements in HbA1c were found (0.9%; P < 0.001 in both sexes). There were no significant differences in clinical characteristics, or in progression of CIMT in men or women according to 2-year quartiles of VFT change.
Our results do not suggest that increased visceral adiposity without body weight changes impacts the CIMT progression in South Korean men or women with T2DM.